Cephalon Inks Deal To Market Fentora In China
This article was originally published in The Pink Sheet Daily
Executive Summary
Beijing Med-Pharm will carry out the clinical development and registration process for select Cephalon products, starting with the Actiq follow on.
You may also be interested in...
Beijing Med-Pharm Inks Deal With KV Pharmaceutical To Bring Clindesse To China
Beijing Med-Pharm will extend its women's health franchise in China with the addition of KV Pharmaceutical Company's Clindesse (clindamycin) for bacterial vaginosis. The company gained exclusive marketing and distribution rights to the product in China in a deal announced July 10
Beijing Med-Pharm Inks Deal With KV Pharmaceutical To Bring Clindesse To China
Marketing and distribution firm will be responsible for completing late-stage clinical development and registration of clindamycin.
Beijing Med-Pharm Inks Deal With KV Pharmaceutical To Bring Clindesse To China
Marketing and distribution firm will be responsible for completing late-stage clinical development and registration of clindamycin.